- Home
- » Tags
- » Barr Pharmaceuticals
Top View
- Drug Companies Participating in MED-Project Stewardship Plan (February 9, 2017)
- WATSON PHARMACEUTICALS, INC. (Exact Name of Registrant As Specified in Its Charter)
- ANALYSIS of AGREEMENT CONTAINING CONSENT ORDERS to AID PUBLIC COMMENT in the Matter of Teva Pharmaceutical Industries Ltd
- MED-Project Participating Drug Companies - King County Washington, March 2020
- Generic Pharmaceuticals Pricing Antitrust Li
- Neuroscience Education Institute Full-Disclosure Form Title/Affiliation
- Form 10-K Amgen Inc
- 0710164 Complaint
- KATHLEEN A. WAGNER, Plaintiff, V. Defendants. OPINION and ORDER
- Niaspan Draft Consolidated and Amended
- 13-6365 Teva Pharmaceuticals Usa, Inc. Section: "J" (4) Et Al
- Overview of Ftc Actions in Pharmaceutical Products and Distribution*
- Provider Manual
- HWLT-0300.Pdf
- Bristol Myers Squibb Co (Bmy)
- In the United States District Court
- ACTAVIS, INC. (Exact Name of Registrant As Specified in Its Charter)
- List of Issuers with No Outstanding Past-Due Share of the Issuer Accounting Support Fee
- 1 0810224 United States of America Before Federal
- 20200915 MED-Project Participant List.Xlsx
- Pharmaceutical Marketing Disclosures
- 2008 Annual Report File
- 2012 Annual Report on the Cover – Eliquis – the Scientific Journey
- Form 10-K Amgen Inc
- Overview of Ftc Actions in Pharmaceutical Products and Distribution*
- Generic Pharmaceuticals Pricing Antitrust Li
- Bitter Pill to Swallow:Putting Teva on A
- List of Issuers with No Outstanding Past-Due Share of the Issuer Accounting Support Fee
- Copycat Consolidation As More Blockbuster Drugs Come Off Patent, Generic Drugmakers Face a Changing Landscape
- Letter to Shareholders
- Competition and Antitrust Issues in the Pharmaceutical Industry
- (NEW) 2019 MED-Project Annual Report
- Federal Register/Vol. 81, No. 192/Tuesday, October 4, 2016
- Mylan Announces Enhancements to Executive Management Team
- La Verdad Acerca De Las Industrias Farmaceuticas
- Generic Pharmaceuticals
- Bristol-Myers Squibb Company 2007 Annual Report
- Fairness Opinion
- In the Supreme Court of Pennsylvania Eastern District
- Marseille, Le
- Agmen Inc. 2009 Annual Report
- Notice of 2021 Annual Meeting and Proxy Statement
- P Number Manufacturer Name P1001 Forest Laboratories, Inc. P1002
- CASE 0:19-Cv-00121-WMW-TNL Document 1 Filed 01/16/19 Page 1 of 355
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
- We Received This After Hours on Friday So the Deadline Is Friday, May 31. From: Office of the Vermont Attorney General <Ago.H